Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
about
Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?Antitubercular therapy in patients with cirrhosis: challenges and optionsEpidemiology of idiosyncratic drug-induced liver injuryRifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature reviewDrug hepatotoxicity.NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.Antituberculosis drug-induced hepatotoxicity in childrenDrug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients.Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.Tuberculosis and nontuberculous mycobacterial infections in older adults.Antituberculosis treatment-induced hepatotoxicity: role of predictive factors.Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment.Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases.An Update on Drug-induced Liver Injury.A guide to the management of tuberculosis in patients with chronic liver disease.Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.
P2860
Q26769973-7F4F8770-CC5B-46B2-85BB-83E34CC66751Q33626827-7A582B29-D1EE-4AD6-B2DF-6F2C63E2513BQ33990236-267FEBCB-1399-4A74-B611-A37BE6039607Q34116293-E2958B14-4E4E-4F58-A6A0-D640C33F13D1Q34512476-08377510-4315-49F1-B1C2-BF63EF48C64BQ34606196-7352D0DC-A635-4167-B4E7-853898437A37Q35096954-C393C922-5AD0-43CE-83F9-26ACE7690ED4Q35534713-63F6AE5F-155E-4917-A868-86F143B5C08AQ36512029-4DAC0D05-C5A2-4869-9FB6-1AC510C8A609Q36515625-B641E406-D93F-4FC5-B22F-C37FE854DDF1Q36680092-C7F6F8B4-F4A7-4DB2-A3E6-E9C49D70A67FQ37043444-9FFD2758-29C3-4C11-9AE1-D607AA134BDCQ37173825-D61D2310-C75E-4BE7-B2B3-836F5717B390Q37278221-5074AA48-63C3-4796-A488-88BE6BC803C6Q37613520-4B7FFC54-5D6B-442B-AF39-917194205628Q37613934-2366A597-F922-4D8B-910B-D87F37C94ECAQ54980590-A0A9494D-A69A-4A19-8420-2C80ABC6EA13
P2860
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
description
1978 nî lūn-bûn
@nan
1978 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@ast
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@en
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@nl
type
label
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@ast
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@en
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@nl
prefLabel
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@ast
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@en
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@nl
P2093
P1476
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis
@en
P2093
C Grönhagen-Riska
P E Hellstrom
P356
10.1164/ARRD.1978.118.3.461
P407
P577
1978-09-01T00:00:00Z